Eric Daniels
Corporate Officer/Principal at KIORA PHARMACEUTICALS, INC.
Net worth: 614 $ as of 2024-05-30
Profile
Eric J.
Daniels is the founder of Okogen, Inc., Bayon Therapeutics, Inc., and Kiora Pharmaceuticals, Inc. He is currently the Chief Development Officer at Kiora Pharmaceuticals, Inc. (2021-present).
Previously, he served as the Chief Executive Officer at OccuRx Pty Ltd.
Dr. Daniels completed his undergraduate degree at the University of California, Berkeley.
He then obtained a doctorate from the David Geffen School of Medicine.
Additionally, he holds an MBA from the Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-06-13 | 1,246 ( 0.00% ) | 614 $ | 2024-05-30 |
Eric Daniels active positions
| Companies | Position | Start |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2021-10-20 |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Founder | - |
| Bayon Therapeutics, Inc. | Founder | - |
Former positions of Eric Daniels
| Companies | Position | End |
|---|---|---|
OccuRx Pty Ltd
 OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Chief Executive Officer | - |
Training of Eric Daniels
| University of California, Berkeley | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
| Anderson School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
OccuRx Pty Ltd
OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Health Technology |
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
| Bayon Therapeutics, Inc. |
- Stock Market
- Insiders
- Eric Daniels
